医薬品リファレンス
Plerixafor
Plerixafor is a medicine in the class miscellaneous. It is used for multiple myeloma.
- 薬効分類: Miscellaneous
- 効能・効果: multiple myeloma
最終更新日 出典: US FDA label
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Miscellaneous
- ATCコード
- L03AX16
- 一般的な剤形
- 注射剤
- 一般的な規格
- 24 mg/1.2 ml
- 商品名
- 3
- 国・市場
- 2
何に使われるか
作用のしくみ
Plerixafor inhibits the CXCR4 chemokine receptor and blocks binding of its ligand SDF-1α, which is involved in the homing of hematopoietic stem cells to the marrow. This results in leukocytosis and increased circulating hematopoietic progenitor cells.
成人の通常用量（添付文書の要約）
HSC mobilization (NHL or MM, with filgrastim): 20 mg fixed dose or 0.24 mg/kg subcutaneously for weight ≤83 kg, about 11 hours before each apheresis, for up to 4 consecutive days; start after 4 days of filgrastim
妊娠と授乳
- 妊娠
- Unsafe Can cause fetal harm based on animal studies (embryo-fetal mortality, structural abnormalities in rats). Use effective contraception during treatment and for one week after the final dose.
- 授乳
- Unsafe No human milk data. Breastfeeding is not recommended during treatment and for one week after the final dose.
報告されている副作用
- Diarrhea
- Nausea
- Injection site reactions
- Fatigue
- Headache
- Arthralgia
禁忌
- History of hypersensitivity to plerixafor
注意が必要な方
- Anaphylactic shock and serious hypersensitivity reactions: observe for at least 30 minutes and until clinically stable; have anaphylaxis treatment available
- May mobilize leukemic cells; not intended for use in patients with leukemia
- Leukocytosis and thrombocytopenia: monitor white blood cell and platelet counts
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Plerixaforの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
WebでPro+を7日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Plerixafor used for?
Plerixafor is a medicine in the class miscellaneous. It is used for Multiple myeloma, Non-hodgkin lymphoma.
What side effects have been reported with Plerixafor?
Diarrhea, Nausea, Injection site reactions, Fatigue, Headache, Arthralgia.
Can Plerixafor be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm based on animal studies (embryo-fetal mortality, structural abnormalities in rats). Use effective contraception during treatment and for one week after the final dose. Breastfeeding: Unsafe. No human milk data. Breastfeeding is not recommended during treatment and for one week after the final dose.
What does Plerixafor interact with?
MediHelp does not list a checked interaction for Plerixafor yet. Always tell your pharmacist about every medicine you take.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
